drugset / Trial / NCT02938962
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
RandomizedParallel-groupTriple-blindPrevention
Summary
The objective of this study is to evaluate and compare the effects of intravenous and topical administration of tranexamic acid during revision hip arthroplasty on blood loss, allogenic blood transfusion rates, length of hospital stay and perioperative complications.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 20 mg/kg | Intravenous |
| Comparator | Tranexamic Acid | Small molecule | 3 g | Intravenous |
Indications
No indication recorded.